Integer Stake Corp (ITGR) Holding Raised by Morgan Stanley

Integer Stake Corp (ITGR) Holding Raised by Morgan Stanley

Morgan Stanley raised its holdings in Integer Holdings Corp (NYSE:ITGR) by 26.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 108,425 shares of the medical equipment provider’s stock after buying an additional 22,598 shares during the quarter. Morgan Stanley owned 0.33% of Integer worth $8,994,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. C M Bidwell & Associates Ltd. acquired a new stake in Integer in the 3rd quarter valued at approximately $219,000. First Quadrant L P CA acquired a new stake in Integer in the 3rd quarter valued at approximately $430,000. United Services Automobile Association grew its holdings in shares of Integer by 15.6% during the 2nd quarter. United Services Automobile Association now owns 6,847 shares of the medical equipment provider’s stock worth $443,000 after purchasing an additional 922 shares in the last quarter. Victory Capital Management Inc. acquired a new stake in shares of Integer during the 3rd quarter worth approximately $473,000. Finally, Seven Eight Capital LP acquired a new stake in shares of Integer during the 3rd quarter worth approximately $489,000. 97.73% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE:ITGR opened at $80.09 on Tuesday. Integer Holdings Corp has a 1-year low of $43.25 and a 1-year high of $90.03. The company has a market cap of $2.55 billion, a PE ratio of 28.50 and a beta of 0.96. The company has a current ratio of 2.41, a quick ratio of 1.32 and a debt-to-equity ratio of 0.88.

Several brokerages have recently weighed in on ITGR. TheStreet lowered Integer from a “b” rating to a “c+” rating in a report on Friday, November 2nd. Royal Bank of Canada lifted their price objective on Integer to $84.00 in a report on Friday, November 2nd. KeyCorp lifted their price objective on Integer from $81.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, November 2nd. Finally, Zacks Investment Research raised Integer from a “hold” rating to a “buy” rating and set a $91.00 price objective on the stock in a report on Friday, January 18th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $85.80.

In other news, Director Pamela G. Bailey sold 5,767 shares of Integer stock in a transaction that occurred on Tuesday, November 20th. The stock was sold at an average price of $83.16, for a total transaction of $479,583.72. Following the sale, the director now owns 53,562 shares of the company’s stock, valued at approximately $4,454,215.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Joseph F. Flanagan sold 13,633 shares of the business’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $86.42, for a total value of $1,178,163.86. Following the completion of the sale, the executive vice president now directly owns 12,622 shares in the company, valued at approximately $1,090,793.24. The disclosure for this sale can be found here. 3.60% of the stock is currently owned by company insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.

See Also: What is the Bid-Ask Spread?

Related posts

Leave a Comment